查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1591972

影像導引治療系統市場：按產品、矯正策略、應用和最終用戶 - 2025-2030 年全球預測

Image-guided Therapy System Market by Product (Computed Tomography Imaging, Intervention X-ray, Magnetic Resonance Imaging), Correction Strategy (Offline, On Line), Application, End User - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 199 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

2023年影像導引治療系統市值為44.6億美元，預計2024年將達到47.9億美元，複合年成長率為7.27%，到2030年將達到73億美元。

影像導引治療系統 (IGTS) 是影像和治療技術的複雜結合，可為手術和治療過程提供精確的介入。這些系統在手術過程中提供即時影像資料，對於實現微創手術、改善患者治療效果以及縮短恢復時間至關重要。這項需求源自於神經病學、心臟病學、整形外科和腫瘤學等各個醫學領域對準確、有效和微創治療的需求不斷成長。最終用途正在擴展到尋求提高手術能力的醫院、診所和研究機構。慢性病盛行率上升、人口老化尋求侵入性較小的醫療程序以及 MRI、 電腦斷層掃描和超音波等診斷成像方式的持續技術進步推動了市場的發展。此外，人工智慧和機器學習應用正在釋放提高資料準確性和治療效率的潛在機會。關鍵的成長要素還包括對醫療基礎設施的投資增加、政府對先進治療技術的激勵以及精準醫學研發的增加。然而，市場面臨設備高成本、需要專業技能的程序複雜以及嚴格的法規環境等限制。持續的挑戰包括網路安全風險和與數位整合系統相關的互通性問題。創新機會存在於開發具有成本效益的可攜式IGTS 解決方案以及整合先進的人工智慧主導分析以獲取預測見解。此外，即時 3D影像處理和擴增實境(AR) 的突破性進展可能會進一步徹底改變手術輔助。企業可以透過投資與高科技公司的合作夥伴關係、加強其研發能力並專注於對先進醫療技術需求不斷成長的新興市場來利用這些機會。儘管面臨挑戰，但市場的動態性質呈現出巨大的突破潛力，並強調了持續創新和策略適應新興技術趨勢和醫療保健需求的重要性。

主要市場統計
基準年[2023] 44.6億美元
預測年份 [2024] 47.9億美元
預測年份 [2030] 73億美元
複合年成長率（%） 7.27%

市場動態：快速發展的影像引導治療系統市場的關鍵市場洞察

影像導引治療系統市場正因供需的動態交互作用而轉變。透過了解這些不斷變化的市場動態，公司可以準備好做出明智的投資決策、完善策略決策並抓住新的商機。全面了解這些趨勢可以幫助企業降低政治、地理、技術、社會和經濟領域的風險，同時消費行為及其對製造成本的影響以及對採購趨勢的影響。

  • 市場促進因素
    • 由於慢性病盛行率上升，老年人口不斷增加
    • 改變對微創手術的偏好
    • 癌症放射治療計劃數量的增加
  • 市場限制因素
    • 影像導引治療系統的初始成本較高
  • 市場機會
    • 影像導引治療系統的持續技術進步
    • 增加策略聯盟和投資
  • 市場挑戰
    • 驗證標準和設備介面標準

波特五力：駕馭影像引導治療系統市場的策略工具

波特的五力框架是理解市場競爭格局的重要工具。波特的五力框架為評估公司的競爭地位和探索策略機會提供了清晰的方法。該框架可幫助公司評估市場動態並確定新業務的盈利。這些見解使公司能夠利用自己的優勢，解決弱點並避免潛在的挑戰，從而確保更強大的市場地位。

PESTLE分析：了解影像導引治療系統市場的外部影響

外部宏觀環境因素在塑造影像引導治療系統市場的績效動態方面發揮著至關重要的作用。對政治、經濟、社會、技術、法律和環境因素的分析提供了應對這些影響所需的資訊。透過調查 PESTLE 因素，公司可以更了解潛在的風險和機會。這種分析可以幫助公司預測法規、消費者偏好和經濟趨勢的變化，並為他們做出積極主動的決策做好準備。

市場佔有率分析 了解影像導引治療系統市場的競爭格局

影像導引治療系統市場的詳細市場佔有率分析可以對供應商績效進行全面評估。公司可以透過比較收益、客戶群和成長率等關鍵指標來揭示其競爭地位。該分析揭示了市場集中、分散和整合的趨勢，為供應商提供了製定策略決策所需的洞察力，使他們能夠在日益激烈的競爭中佔有一席之地。

FPNV 定位矩陣影像導引治療系統市場供應商的績效評估

FPNV 定位矩陣是評估影像導引治療系統市場供應商的重要工具。此矩陣允許業務組織根據供應商的商務策略和產品滿意度評估供應商，從而做出符合其目標的明智決策。這四個象限使您能夠清晰、準確地分類供應商，並確定最能滿足您的策略目標的合作夥伴和解決方案。

策略分析和建議，以規劃影像引導治療系統市場的成功之路

對於旨在加強其在全球市場的影響力的公司來說，對影像導引治療系統市場的策略分析至關重要。透過審查關鍵資源、能力和績效指標，公司可以識別成長機會並努力改進。這種方法使您能夠克服競爭環境中的挑戰，利用新的商機並取得長期成功。

本報告提供了涵蓋關鍵重點領域的市場全面分析：

1. 市場滲透率：詳細檢視當前市場環境、主要企業的廣泛資料、評估其在市場中的影響力和整體影響力。

2. 市場開拓：辨識新興市場的成長機會，評估現有領域的擴張潛力，並提供未來成長的策略藍圖。

3. 市場多元化：分析近期產品發布、開拓地區、關鍵產業進展、塑造市場的策略投資。

4. 競爭評估與情報：徹底分析競爭格局，檢驗市場佔有率、業務策略、產品系列、認證、監理核准、專利趨勢、主要企業的技術進步等。

5. 產品開發與創新：重點在於有望推動未來市場成長的最尖端科技、研發活動和產品創新。

我們也回答重要問題，以幫助相關人員做出明智的決策：

1.目前的市場規模和未來的成長預測是多少？

2. 哪些產品、區隔市場和地區提供最佳投資機會？

3.塑造市場的主要技術趨勢和監管影響是什麼？

4.主要廠商的市場佔有率和競爭地位如何？

5. 推動供應商市場進入和退出策略的收益來源和策略機會是什麼？

目錄

第1章 前言

第2章調查方法

第3章執行摘要

第4章市場概況

第5章市場洞察

  • 市場動態
    • 促進因素
      • 由於慢性病盛行率上升，老年人口不斷增加
      • 改變對微創手術的偏好
      • 癌症放射治療力道加大
    • 抑制因素
      • 影像導引治療系統的初始成本較高
    • 機會
      • 影像導引治療系統的持續技術進步
      • 增加策略聯盟和投資
    • 任務
      • 檢驗標準和設備介面標準
  • 市場區隔分析
  • 波特五力分析
  • PESTEL分析
    • 政治的
    • 經濟
    • 社群
    • 技術的
    • 合法地
    • 環境

第6章影像導引治療系統市場：依產品

  • 電腦斷層掃描影像
  • 介入X光檢查
  • 磁振造影
  • 正子斷層掃描
  • 超音波系統

第7章依修改策略分類的圖像導引治療系統市場

  • 離線
  • 線上

第8章影像導引治療系統市場：依應用分類

  • 胃腸病學
  • 神經外科
  • 腫瘤學
  • 整形外科

第 9 章影像導引治療系統市場：依最終使用者分類

  • 門診手術中心
  • 診所
  • 醫院
  • 研究/學術機構

第10章美洲影像導引治療系統市場

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美國

第11章亞太影像導引治療系統市場

  • 澳洲
  • 中國
  • 印度
  • 印尼
  • 日本
  • 馬來西亞
  • 菲律賓
  • 新加坡
  • 韓國
  • 台灣
  • 泰國
  • 越南

第12章歐洲、中東和非洲影像導引治療系統市場

  • 丹麥
  • 埃及
  • 芬蘭
  • 法國
  • 德國
  • 以色列
  • 義大利
  • 荷蘭
  • 奈及利亞
  • 挪威
  • 波蘭
  • 卡達
  • 俄羅斯
  • 沙烏地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公國
  • 英國

第13章競爭格局

  • 2023 年市場佔有率分析
  • FPNV 定位矩陣，2023
  • 競爭情境分析
  • 戰略分析和建議

公司名單

  • Abbott Laboratories
  • Analogic Corporation
  • Brainlab AG
  • Canon Medical Systems Corporation
  • Elekta AB
  • FUJIFILM Holdings Corporation
  • GE Healthcare
  • Hitachi, Ltd.
  • KARL STORZ SE & Co. KG
  • Koninklijke Philips NV
  • Medtronic PLC
  • Olympus Corporation
  • Siemens Healthineers AG
  • Stryker Corporation
  • Toshiba Corporation
  • Varian Medical Systems, Inc.
Product Code: MRR-43127F7279B1

The Image-guided Therapy System Market was valued at USD 4.46 billion in 2023, expected to reach USD 4.79 billion in 2024, and is projected to grow at a CAGR of 7.27%, to USD 7.30 billion by 2030.

Image-guided therapy systems (IGTS) represent an advanced intersection of imaging and therapeutic technologies, providing precise interventions in surgical and therapeutic procedures. These systems are crucial in enabling minimally invasive surgeries, improving patient outcomes, and reducing recovery times by providing real-time imaging data during procedures. The necessity arises from the increased demand for accurate, effective, and less invasive treatments across various medical fields, including neurology, cardiology, orthopedics, and oncology. End-use extends to hospitals, clinics, and research institutions seeking to enhance their surgical capabilities. The market is poised for growth driven by the rising prevalence of chronic diseases, an aging population demanding less invasive medical procedures, and continuous technological advancements in imaging modalities such as MRI, CT scans, and ultrasound. Furthermore, artificial intelligence and machine learning applications are unlocking potential opportunities for enhanced data accuracy and procedure efficiency. Key growth factors also include increasing healthcare infrastructure investments, government incentives for advanced therapeutic technologies, and expanding R&D in precision medicine. Nevertheless, the market faces limitations such as high costs of devices, procedural complexities requiring specialized skills, and stringent regulatory environments. Ongoing challenges include cybersecurity risks associated with digitally integrated systems and interoperability issues. Opportunities for innovation exist in developing cost-effective, portable IGTS solutions and integrating advanced AI-driven analytics for predictive insights. Additionally, breakthroughs in real-time 3D imaging and augmented reality can further revolutionize surgical assistance. Businesses can capitalize on these opportunities by investing in partnerships with tech companies, enhancing R&D capabilities, and focusing on emerging markets where the demand for advanced medical technology is increasing. Despite challenges, the market's dynamic nature indicates significant potential for breakthroughs, underscoring the importance of continuous innovation and strategic adaptation to emerging technological trends and healthcare needs.

KEY MARKET STATISTICS
Base Year [2023] USD 4.46 billion
Estimated Year [2024] USD 4.79 billion
Forecast Year [2030] USD 7.30 billion
CAGR (%) 7.27%

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Image-guided Therapy System Market

The Image-guided Therapy System Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Increase in the geriatric population with rising prevalence rate of chronic conditions
    • Shifting preference for minimally invasive surgeries
    • Rising in the number of initiatives for cancer radiotherapy
  • Market Restraints
    • High initial cost associated with image-guided therapy system
  • Market Opportunities
    • Ongoing technological advancements in image-guided therapy system
    • Increasing strategic alliances and investments
  • Market Challenges
    • Validation standards and device interface standards

Porter's Five Forces: A Strategic Tool for Navigating the Image-guided Therapy System Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Image-guided Therapy System Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Image-guided Therapy System Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Image-guided Therapy System Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Image-guided Therapy System Market

A detailed market share analysis in the Image-guided Therapy System Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Image-guided Therapy System Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Image-guided Therapy System Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Image-guided Therapy System Market

A strategic analysis of the Image-guided Therapy System Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Image-guided Therapy System Market, highlighting leading vendors and their innovative profiles. These include Abbott Laboratories, Analogic Corporation, Brainlab AG, Canon Medical Systems Corporation, Elekta AB, FUJIFILM Holdings Corporation, GE Healthcare, Hitachi, Ltd., KARL STORZ SE & Co. KG, Koninklijke Philips N.V., Medtronic PLC, Olympus Corporation, Siemens Healthineers AG, Stryker Corporation, Toshiba Corporation, and Varian Medical Systems, Inc..

Market Segmentation & Coverage

This research report categorizes the Image-guided Therapy System Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Product, market is studied across Computed Tomography Imaging, Intervention X-ray, Magnetic Resonance Imaging, Positron Emission Tomography, and Ultrasound Systems.
  • Based on Correction Strategy, market is studied across Offline and On Line.
  • Based on Application, market is studied across Gastroenterology, Neurosurgery, Oncology, and Orthopedic Surgery.
  • Based on End User, market is studied across Ambulatory Surgery Centers, Clinics, Hospitals, and Research & Academic Institutes.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Increase in the geriatric population with rising prevalence rate of chronic conditions
      • 5.1.1.2. Shifting preference for minimally invasive surgeries
      • 5.1.1.3. Rising in the number of initiatives for cancer radiotherapy
    • 5.1.2. Restraints
      • 5.1.2.1. High initial cost associated with image-guided therapy system
    • 5.1.3. Opportunities
      • 5.1.3.1. Ongoing technological advancements in image-guided therapy system
      • 5.1.3.2. Increasing strategic alliances and investments
    • 5.1.4. Challenges
      • 5.1.4.1. Validation standards and device interface standards
  • 5.2. Market Segmentation Analysis
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Image-guided Therapy System Market, by Product

  • 6.1. Introduction
  • 6.2. Computed Tomography Imaging
  • 6.3. Intervention X-ray
  • 6.4. Magnetic Resonance Imaging
  • 6.5. Positron Emission Tomography
  • 6.6. Ultrasound Systems

7. Image-guided Therapy System Market, by Correction Strategy

  • 7.1. Introduction
  • 7.2. Offline
  • 7.3. On Line

8. Image-guided Therapy System Market, by Application

  • 8.1. Introduction
  • 8.2. Gastroenterology
  • 8.3. Neurosurgery
  • 8.4. Oncology
  • 8.5. Orthopedic Surgery

9. Image-guided Therapy System Market, by End User

  • 9.1. Introduction
  • 9.2. Ambulatory Surgery Centers
  • 9.3. Clinics
  • 9.4. Hospitals
  • 9.5. Research & Academic Institutes

10. Americas Image-guided Therapy System Market

  • 10.1. Introduction
  • 10.2. Argentina
  • 10.3. Brazil
  • 10.4. Canada
  • 10.5. Mexico
  • 10.6. United States

11. Asia-Pacific Image-guided Therapy System Market

  • 11.1. Introduction
  • 11.2. Australia
  • 11.3. China
  • 11.4. India
  • 11.5. Indonesia
  • 11.6. Japan
  • 11.7. Malaysia
  • 11.8. Philippines
  • 11.9. Singapore
  • 11.10. South Korea
  • 11.11. Taiwan
  • 11.12. Thailand
  • 11.13. Vietnam

12. Europe, Middle East & Africa Image-guided Therapy System Market

  • 12.1. Introduction
  • 12.2. Denmark
  • 12.3. Egypt
  • 12.4. Finland
  • 12.5. France
  • 12.6. Germany
  • 12.7. Israel
  • 12.8. Italy
  • 12.9. Netherlands
  • 12.10. Nigeria
  • 12.11. Norway
  • 12.12. Poland
  • 12.13. Qatar
  • 12.14. Russia
  • 12.15. Saudi Arabia
  • 12.16. South Africa
  • 12.17. Spain
  • 12.18. Sweden
  • 12.19. Switzerland
  • 12.20. Turkey
  • 12.21. United Arab Emirates
  • 12.22. United Kingdom

13. Competitive Landscape

  • 13.1. Market Share Analysis, 2023
  • 13.2. FPNV Positioning Matrix, 2023
  • 13.3. Competitive Scenario Analysis
  • 13.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. Abbott Laboratories
  • 2. Analogic Corporation
  • 3. Brainlab AG
  • 4. Canon Medical Systems Corporation
  • 5. Elekta AB
  • 6. FUJIFILM Holdings Corporation
  • 7. GE Healthcare
  • 8. Hitachi, Ltd.
  • 9. KARL STORZ SE & Co. KG
  • 10. Koninklijke Philips N.V.
  • 11. Medtronic PLC
  • 12. Olympus Corporation
  • 13. Siemens Healthineers AG
  • 14. Stryker Corporation
  • 15. Toshiba Corporation
  • 16. Varian Medical Systems, Inc.

LIST OF FIGURES

  • FIGURE 1. IMAGE-GUIDED THERAPY SYSTEM MARKET RESEARCH PROCESS
  • FIGURE 2. IMAGE-GUIDED THERAPY SYSTEM MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL IMAGE-GUIDED THERAPY SYSTEM MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL IMAGE-GUIDED THERAPY SYSTEM MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL IMAGE-GUIDED THERAPY SYSTEM MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL IMAGE-GUIDED THERAPY SYSTEM MARKET SIZE, BY PRODUCT, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL IMAGE-GUIDED THERAPY SYSTEM MARKET SIZE, BY PRODUCT, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL IMAGE-GUIDED THERAPY SYSTEM MARKET SIZE, BY CORRECTION STRATEGY, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL IMAGE-GUIDED THERAPY SYSTEM MARKET SIZE, BY CORRECTION STRATEGY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. GLOBAL IMAGE-GUIDED THERAPY SYSTEM MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
  • FIGURE 11. GLOBAL IMAGE-GUIDED THERAPY SYSTEM MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. GLOBAL IMAGE-GUIDED THERAPY SYSTEM MARKET SIZE, BY END USER, 2023 VS 2030 (%)
  • FIGURE 13. GLOBAL IMAGE-GUIDED THERAPY SYSTEM MARKET SIZE, BY END USER, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. AMERICAS IMAGE-GUIDED THERAPY SYSTEM MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 15. AMERICAS IMAGE-GUIDED THERAPY SYSTEM MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. UNITED STATES IMAGE-GUIDED THERAPY SYSTEM MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 17. UNITED STATES IMAGE-GUIDED THERAPY SYSTEM MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. ASIA-PACIFIC IMAGE-GUIDED THERAPY SYSTEM MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 19. ASIA-PACIFIC IMAGE-GUIDED THERAPY SYSTEM MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 20. EUROPE, MIDDLE EAST & AFRICA IMAGE-GUIDED THERAPY SYSTEM MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 21. EUROPE, MIDDLE EAST & AFRICA IMAGE-GUIDED THERAPY SYSTEM MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 22. IMAGE-GUIDED THERAPY SYSTEM MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 23. IMAGE-GUIDED THERAPY SYSTEM MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. IMAGE-GUIDED THERAPY SYSTEM MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL IMAGE-GUIDED THERAPY SYSTEM MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL IMAGE-GUIDED THERAPY SYSTEM MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL IMAGE-GUIDED THERAPY SYSTEM MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. IMAGE-GUIDED THERAPY SYSTEM MARKET DYNAMICS
  • TABLE 7. GLOBAL IMAGE-GUIDED THERAPY SYSTEM MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL IMAGE-GUIDED THERAPY SYSTEM MARKET SIZE, BY COMPUTED TOMOGRAPHY IMAGING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL IMAGE-GUIDED THERAPY SYSTEM MARKET SIZE, BY INTERVENTION X-RAY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL IMAGE-GUIDED THERAPY SYSTEM MARKET SIZE, BY MAGNETIC RESONANCE IMAGING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL IMAGE-GUIDED THERAPY SYSTEM MARKET SIZE, BY POSITRON EMISSION TOMOGRAPHY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL IMAGE-GUIDED THERAPY SYSTEM MARKET SIZE, BY ULTRASOUND SYSTEMS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL IMAGE-GUIDED THERAPY SYSTEM MARKET SIZE, BY CORRECTION STRATEGY, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL IMAGE-GUIDED THERAPY SYSTEM MARKET SIZE, BY OFFLINE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL IMAGE-GUIDED THERAPY SYSTEM MARKET SIZE, BY ON LINE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL IMAGE-GUIDED THERAPY SYSTEM MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL IMAGE-GUIDED THERAPY SYSTEM MARKET SIZE, BY GASTROENTEROLOGY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. GLOBAL IMAGE-GUIDED THERAPY SYSTEM MARKET SIZE, BY NEUROSURGERY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 19. GLOBAL IMAGE-GUIDED THERAPY SYSTEM MARKET SIZE, BY ONCOLOGY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 20. GLOBAL IMAGE-GUIDED THERAPY SYSTEM MARKET SIZE, BY ORTHOPEDIC SURGERY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 21. GLOBAL IMAGE-GUIDED THERAPY SYSTEM MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 22. GLOBAL IMAGE-GUIDED THERAPY SYSTEM MARKET SIZE, BY AMBULATORY SURGERY CENTERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 23. GLOBAL IMAGE-GUIDED THERAPY SYSTEM MARKET SIZE, BY CLINICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 24. GLOBAL IMAGE-GUIDED THERAPY SYSTEM MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 25. GLOBAL IMAGE-GUIDED THERAPY SYSTEM MARKET SIZE, BY RESEARCH & ACADEMIC INSTITUTES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 26. AMERICAS IMAGE-GUIDED THERAPY SYSTEM MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 27. AMERICAS IMAGE-GUIDED THERAPY SYSTEM MARKET SIZE, BY CORRECTION STRATEGY, 2018-2030 (USD MILLION)
  • TABLE 28. AMERICAS IMAGE-GUIDED THERAPY SYSTEM MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 29. AMERICAS IMAGE-GUIDED THERAPY SYSTEM MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 30. AMERICAS IMAGE-GUIDED THERAPY SYSTEM MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 31. ARGENTINA IMAGE-GUIDED THERAPY SYSTEM MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 32. ARGENTINA IMAGE-GUIDED THERAPY SYSTEM MARKET SIZE, BY CORRECTION STRATEGY, 2018-2030 (USD MILLION)
  • TABLE 33. ARGENTINA IMAGE-GUIDED THERAPY SYSTEM MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 34. ARGENTINA IMAGE-GUIDED THERAPY SYSTEM MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 35. BRAZIL IMAGE-GUIDED THERAPY SYSTEM MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 36. BRAZIL IMAGE-GUIDED THERAPY SYSTEM MARKET SIZE, BY CORRECTION STRATEGY, 2018-2030 (USD MILLION)
  • TABLE 37. BRAZIL IMAGE-GUIDED THERAPY SYSTEM MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 38. BRAZIL IMAGE-GUIDED THERAPY SYSTEM MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 39. CANADA IMAGE-GUIDED THERAPY SYSTEM MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 40. CANADA IMAGE-GUIDED THERAPY SYSTEM MARKET SIZE, BY CORRECTION STRATEGY, 2018-2030 (USD MILLION)
  • TABLE 41. CANADA IMAGE-GUIDED THERAPY SYSTEM MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 42. CANADA IMAGE-GUIDED THERAPY SYSTEM MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 43. MEXICO IMAGE-GUIDED THERAPY SYSTEM MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 44. MEXICO IMAGE-GUIDED THERAPY SYSTEM MARKET SIZE, BY CORRECTION STRATEGY, 2018-2030 (USD MILLION)
  • TABLE 45. MEXICO IMAGE-GUIDED THERAPY SYSTEM MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 46. MEXICO IMAGE-GUIDED THERAPY SYSTEM MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 47. UNITED STATES IMAGE-GUIDED THERAPY SYSTEM MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 48. UNITED STATES IMAGE-GUIDED THERAPY SYSTEM MARKET SIZE, BY CORRECTION STRATEGY, 2018-2030 (USD MILLION)
  • TABLE 49. UNITED STATES IMAGE-GUIDED THERAPY SYSTEM MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 50. UNITED STATES IMAGE-GUIDED THERAPY SYSTEM MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 51. UNITED STATES IMAGE-GUIDED THERAPY SYSTEM MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 52. ASIA-PACIFIC IMAGE-GUIDED THERAPY SYSTEM MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 53. ASIA-PACIFIC IMAGE-GUIDED THERAPY SYSTEM MARKET SIZE, BY CORRECTION STRATEGY, 2018-2030 (USD MILLION)
  • TABLE 54. ASIA-PACIFIC IMAGE-GUIDED THERAPY SYSTEM MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 55. ASIA-PACIFIC IMAGE-GUIDED THERAPY SYSTEM MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 56. ASIA-PACIFIC IMAGE-GUIDED THERAPY SYSTEM MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 57. AUSTRALIA IMAGE-GUIDED THERAPY SYSTEM MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 58. AUSTRALIA IMAGE-GUIDED THERAPY SYSTEM MARKET SIZE, BY CORRECTION STRATEGY, 2018-2030 (USD MILLION)
  • TABLE 59. AUSTRALIA IMAGE-GUIDED THERAPY SYSTEM MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 60. AUSTRALIA IMAGE-GUIDED THERAPY SYSTEM MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 61. CHINA IMAGE-GUIDED THERAPY SYSTEM MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 62. CHINA IMAGE-GUIDED THERAPY SYSTEM MARKET SIZE, BY CORRECTION STRATEGY, 2018-2030 (USD MILLION)
  • TABLE 63. CHINA IMAGE-GUIDED THERAPY SYSTEM MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 64. CHINA IMAGE-GUIDED THERAPY SYSTEM MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 65. INDIA IMAGE-GUIDED THERAPY SYSTEM MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 66. INDIA IMAGE-GUIDED THERAPY SYSTEM MARKET SIZE, BY CORRECTION STRATEGY, 2018-2030 (USD MILLION)
  • TABLE 67. INDIA IMAGE-GUIDED THERAPY SYSTEM MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 68. INDIA IMAGE-GUIDED THERAPY SYSTEM MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 69. INDONESIA IMAGE-GUIDED THERAPY SYSTEM MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 70. INDONESIA IMAGE-GUIDED THERAPY SYSTEM MARKET SIZE, BY CORRECTION STRATEGY, 2018-2030 (USD MILLION)
  • TABLE 71. INDONESIA IMAGE-GUIDED THERAPY SYSTEM MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 72. INDONESIA IMAGE-GUIDED THERAPY SYSTEM MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 73. JAPAN IMAGE-GUIDED THERAPY SYSTEM MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 74. JAPAN IMAGE-GUIDED THERAPY SYSTEM MARKET SIZE, BY CORRECTION STRATEGY, 2018-2030 (USD MILLION)
  • TABLE 75. JAPAN IMAGE-GUIDED THERAPY SYSTEM MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 76. JAPAN IMAGE-GUIDED THERAPY SYSTEM MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 77. MALAYSIA IMAGE-GUIDED THERAPY SYSTEM MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 78. MALAYSIA IMAGE-GUIDED THERAPY SYSTEM MARKET SIZE, BY CORRECTION STRATEGY, 2018-2030 (USD MILLION)
  • TABLE 79. MALAYSIA IMAGE-GUIDED THERAPY SYSTEM MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 80. MALAYSIA IMAGE-GUIDED THERAPY SYSTEM MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 81. PHILIPPINES IMAGE-GUIDED THERAPY SYSTEM MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 82. PHILIPPINES IMAGE-GUIDED THERAPY SYSTEM MARKET SIZE, BY CORRECTION STRATEGY, 2018-2030 (USD MILLION)
  • TABLE 83. PHILIPPINES IMAGE-GUIDED THERAPY SYSTEM MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 84. PHILIPPINES IMAGE-GUIDED THERAPY SYSTEM MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 85. SINGAPORE IMAGE-GUIDED THERAPY SYSTEM MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 86. SINGAPORE IMAGE-GUIDED THERAPY SYSTEM MARKET SIZE, BY CORRECTION STRATEGY, 2018-2030 (USD MILLION)
  • TABLE 87. SINGAPORE IMAGE-GUIDED THERAPY SYSTEM MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 88. SINGAPORE IMAGE-GUIDED THERAPY SYSTEM MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 89. SOUTH KOREA IMAGE-GUIDED THERAPY SYSTEM MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 90. SOUTH KOREA IMAGE-GUIDED THERAPY SYSTEM MARKET SIZE, BY CORRECTION STRATEGY, 2018-2030 (USD MILLION)
  • TABLE 91. SOUTH KOREA IMAGE-GUIDED THERAPY SYSTEM MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 92. SOUTH KOREA IMAGE-GUIDED THERAPY SYSTEM MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 93. TAIWAN IMAGE-GUIDED THERAPY SYSTEM MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 94. TAIWAN IMAGE-GUIDED THERAPY SYSTEM MARKET SIZE, BY CORRECTION STRATEGY, 2018-2030 (USD MILLION)
  • TABLE 95. TAIWAN IMAGE-GUIDED THERAPY SYSTEM MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 96. TAIWAN IMAGE-GUIDED THERAPY SYSTEM MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 97. THAILAND IMAGE-GUIDED THERAPY SYSTEM MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 98. THAILAND IMAGE-GUIDED THERAPY SYSTEM MARKET SIZE, BY CORRECTION STRATEGY, 2018-2030 (USD MILLION)
  • TABLE 99. THAILAND IMAGE-GUIDED THERAPY SYSTEM MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 100. THAILAND IMAGE-GUIDED THERAPY SYSTEM MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 101. VIETNAM IMAGE-GUIDED THERAPY SYSTEM MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 102. VIETNAM IMAGE-GUIDED THERAPY SYSTEM MARKET SIZE, BY CORRECTION STRATEGY, 2018-2030 (USD MILLION)
  • TABLE 103. VIETNAM IMAGE-GUIDED THERAPY SYSTEM MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 104. VIETNAM IMAGE-GUIDED THERAPY SYSTEM MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 105. EUROPE, MIDDLE EAST & AFRICA IMAGE-GUIDED THERAPY SYSTEM MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 106. EUROPE, MIDDLE EAST & AFRICA IMAGE-GUIDED THERAPY SYSTEM MARKET SIZE, BY CORRECTION STRATEGY, 2018-2030 (USD MILLION)
  • TABLE 107. EUROPE, MIDDLE EAST & AFRICA IMAGE-GUIDED THERAPY SYSTEM MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 108. EUROPE, MIDDLE EAST & AFRICA IMAGE-GUIDED THERAPY SYSTEM MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 109. EUROPE, MIDDLE EAST & AFRICA IMAGE-GUIDED THERAPY SYSTEM MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 110. DENMARK IMAGE-GUIDED THERAPY SYSTEM MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 111. DENMARK IMAGE-GUIDED THERAPY SYSTEM MARKET SIZE, BY CORRECTION STRATEGY, 2018-2030 (USD MILLION)
  • TABLE 112. DENMARK IMAGE-GUIDED THERAPY SYSTEM MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 113. DENMARK IMAGE-GUIDED THERAPY SYSTEM MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 114. EGYPT IMAGE-GUIDED THERAPY SYSTEM MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 115. EGYPT IMAGE-GUIDED THERAPY SYSTEM MARKET SIZE, BY CORRECTION STRATEGY, 2018-2030 (USD MILLION)
  • TABLE 116. EGYPT IMAGE-GUIDED THERAPY SYSTEM MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 117. EGYPT IMAGE-GUIDED THERAPY SYSTEM MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 118. FINLAND IMAGE-GUIDED THERAPY SYSTEM MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 119. FINLAND IMAGE-GUIDED THERAPY SYSTEM MARKET SIZE, BY CORRECTION STRATEGY, 2018-2030 (USD MILLION)
  • TABLE 120. FINLAND IMAGE-GUIDED THERAPY SYSTEM MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 121. FINLAND IMAGE-GUIDED THERAPY SYSTEM MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 122. FRANCE IMAGE-GUIDED THERAPY SYSTEM MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 123. FRANCE IMAGE-GUIDED THERAPY SYSTEM MARKET SIZE, BY CORRECTION STRATEGY, 2018-2030 (USD MILLION)
  • TABLE 124. FRANCE IMAGE-GUIDED THERAPY SYSTEM MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 125. FRANCE IMAGE-GUIDED THERAPY SYSTEM MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 126. GERMANY IMAGE-GUIDED THERAPY SYSTEM MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 127. GERMANY IMAGE-GUIDED THERAPY SYSTEM MARKET SIZE, BY CORRECTION STRATEGY, 2018-2030 (USD MILLION)
  • TABLE 128. GERMANY IMAGE-GUIDED THERAPY SYSTEM MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 129. GERMANY IMAGE-GUIDED THERAPY SYSTEM MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 130. ISRAEL IMAGE-GUIDED THERAPY SYSTEM MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 131. ISRAEL IMAGE-GUIDED THERAPY SYSTEM MARKET SIZE, BY CORRECTION STRATEGY, 2018-2030 (USD MILLION)
  • TABLE 132. ISRAEL IMAGE-GUIDED THERAPY SYSTEM MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 133. ISRAEL IMAGE-GUIDED THERAPY SYSTEM MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 134. ITALY IMAGE-GUIDED THERAPY SYSTEM MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 135. ITALY IMAGE-GUIDED THERAPY SYSTEM MARKET SIZE, BY CORRECTION STRATEGY, 2018-2030 (USD MILLION)
  • TABLE 136. ITALY IMAGE-GUIDED THERAPY SYSTEM MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 137. ITALY IMAGE-GUIDED THERAPY SYSTEM MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 138. NETHERLANDS IMAGE-GUIDED THERAPY SYSTEM MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 139. NETHERLANDS IMAGE-GUIDED THERAPY SYSTEM MARKET SIZE, BY CORRECTION STRATEGY, 2018-2030 (USD MILLION)
  • TABLE 140. NETHERLANDS IMAGE-GUIDED THERAPY SYSTEM MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 141. NETHERLANDS IMAGE-GUIDED THERAPY SYSTEM MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 142. NIGERIA IMAGE-GUIDED THERAPY SYSTEM MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 143. NIGERIA IMAGE-GUIDED THERAPY SYSTEM MARKET SIZE, BY CORRECTION STRATEGY, 2018-2030 (USD MILLION)
  • TABLE 144. NIGERIA IMAGE-GUIDED THERAPY SYSTEM MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 145. NIGERIA IMAGE-GUIDED THERAPY SYSTEM MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 146. NORWAY IMAGE-GUIDED THERAPY SYSTEM MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 147. NORWAY IMAGE-GUIDED THERAPY SYSTEM MARKET SIZE, BY CORRECTION STRATEGY, 2018-2030 (USD MILLION)
  • TABLE 148. NORWAY IMAGE-GUIDED THERAPY SYSTEM MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 149. NORWAY IMAGE-GUIDED THERAPY SYSTEM MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 150. POLAND IMAGE-GUIDED THERAPY SYSTEM MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 151. POLAND IMAGE-GUIDED THERAPY SYSTEM MARKET SIZE, BY CORRECTION STRATEGY, 2018-2030 (USD MILLION)
  • TABLE 152. POLAND IMAGE-GUIDED THERAPY SYSTEM MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 153. POLAND IMAGE-GUIDED THERAPY SYSTEM MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 154. QATAR IMAGE-GUIDED THERAPY SYSTEM MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 155. QATAR IMAGE-GUIDED THERAPY SYSTEM MARKET SIZE, BY CORRECTION STRATEGY, 2018-2030 (USD MILLION)
  • TABLE 156. QATAR IMAGE-GUIDED THERAPY SYSTEM MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 157. QATAR IMAGE-GUIDED THERAPY SYSTEM MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 158. RUSSIA IMAGE-GUIDED THERAPY SYSTEM MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 159. RUSSIA IMAGE-GUIDED THERAPY SYSTEM MARKET SIZE, BY CORRECTION STRATEGY, 2018-2030 (USD MILLION)
  • TABLE 160. RUSSIA IMAGE-GUIDED THERAPY SYSTEM MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 161. RUSSIA IMAGE-GUIDED THERAPY SYSTEM MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 162. SAUDI ARABIA IMAGE-GUIDED THERAPY SYSTEM MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 163. SAUDI ARABIA IMAGE-GUIDED THERAPY SYSTEM MARKET SIZE, BY CORRECTION STRATEGY, 2018-2030 (USD MILLION)
  • TABLE 164. SAUDI ARABIA IMAGE-GUIDED THERAPY SYSTEM MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 165. SAUDI ARABIA IMAGE-GUIDED THERAPY SYSTEM MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 166. SOUTH AFRICA IMAGE-GUIDED THERAPY SYSTEM MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 167. SOUTH AFRICA IMAGE-GUIDED THERAPY SYSTEM MARKET SIZE, BY CORRECTION STRATEGY, 2018-2030 (USD MILLION)
  • TABLE 168. SOUTH AFRICA IMAGE-GUIDED THERAPY SYSTEM MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 169. SOUTH AFRICA IMAGE-GUIDED THERAPY SYSTEM MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 170. SPAIN IMAGE-GUIDED THERAPY SYSTEM MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 171. SPAIN IMAGE-GUIDED THERAPY SYSTEM MARKET SIZE, BY CORRECTION STRATEGY, 2018-2030 (USD MILLION)
  • TABLE 172. SPAIN IMAGE-GUIDED THERAPY SYSTEM MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 173. SPAIN IMAGE-GUIDED THERAPY SYSTEM MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 174. SWEDEN IMAGE-GUIDED THERAPY SYSTEM MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 175. SWEDEN IMAGE-GUIDED THERAPY SYSTEM MARKET SIZE, BY CORRECTION STRATEGY, 2018-2030 (USD MILLION)
  • TABLE 176. SWEDEN IMAGE-GUIDED THERAPY SYSTEM MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 177. SWEDEN IMAGE-GUIDED THERAPY SYSTEM MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 178. SWITZERLAND IMAGE-GUIDED THERAPY SYSTEM MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 179. SWITZERLAND IMAGE-GUIDED THERAPY SYSTEM MARKET SIZE, BY CORRECTION STRATEGY, 2018-2030 (USD MILLION)
  • TABLE 180. SWITZERLAND IMAGE-GUIDED THERAPY SYSTEM MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 181. SWITZERLAND IMAGE-GUIDED THERAPY SYSTEM MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 182. TURKEY IMAGE-GUIDED THERAPY SYSTEM MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 183. TURKEY IMAGE-GUIDED THERAPY SYSTEM MARKET SIZE, BY CORRECTION STRATEGY, 2018-2030 (USD MILLION)
  • TABLE 184. TURKEY IMAGE-GUIDED THERAPY SYSTEM MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 185. TURKEY IMAGE-GUIDED THERAPY SYSTEM MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 186. UNITED ARAB EMIRATES IMAGE-GUIDED THERAPY SYSTEM MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 187. UNITED ARAB EMIRATES IMAGE-GUIDED THERAPY SYSTEM MARKET SIZE, BY CORRECTION STRATEGY, 2018-2030 (USD MILLION)
  • TABLE 188. UNITED ARAB EMIRATES IMAGE-GUIDED THERAPY SYSTEM MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 189. UNITED ARAB EMIRATES IMAGE-GUIDED THERAPY SYSTEM MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 190. UNITED KINGDOM IMAGE-GUIDED THERAPY SYSTEM MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 191. UNITED KINGDOM IMAGE-GUIDED THERAPY SYSTEM MARKET SIZE, BY CORRECTION STRATEGY, 2018-2030 (USD MILLION)
  • TABLE 192. UNITED KINGDOM IMAGE-GUIDED THERAPY SYSTEM MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 193. UNITED KINGDOM IMAGE-GUIDED THERAPY SYSTEM MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 194. IMAGE-GUIDED THERAPY SYSTEM MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 195. IMAGE-GUIDED THERAPY SYSTEM MARKET, FPNV POSITIONING MATRIX, 2023